Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36: Let’s Not Go Back in Time! What Have We Learned in the Treatment of Localized Prostate Cancer? Applicability of the ENACT Randomized Clinical Trial in Clinical Practice

Detalles Bibliográficos
Autores principales: Gómez Rivas, Juan, Gandaglia, Giorgio, Montorsi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672367/
https://www.ncbi.nlm.nih.gov/pubmed/36405303
http://dx.doi.org/10.1016/j.euros.2022.09.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672367/
https://www.ncbi.nlm.nih.gov/pubmed/36405303
http://dx.doi.org/10.1016/j.euros.2022.09.022

Ejemplares similares